Table 2_Harnessing mRNA technology against Fasciola hepatica: Immunological insights from a fatty acid binding protein vaccine.docx
<p>mRNA platforms offer a promising strategy to overcome limitations in helminth vaccinology. We used the helminth Fasciola hepatica, which is a major veterinary and zoonotic pathogen for which no licensed vaccine exists, as a test case. We engineered a codon-optimized mRNA encoding the F. hep...
保存先:
| 第一著者: | |
|---|---|
| その他の著者: | , , , , , , , , , , |
| 出版事項: |
2025
|
| 主題: | |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|